These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20651641)

  • 1. Emergence of Cryptococcus gattii-- Pacific Northwest, 2004-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(28):865-8. PubMed ID: 20651641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States.
    Byrnes EJ; Bildfell RJ; Frank SA; Mitchell TG; Marr KA; Heitman J
    J Infect Dis; 2009 Apr; 199(7):1081-6. PubMed ID: 19220140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spread of Cryptococcus gattii into Pacific Northwest region of the United States.
    Datta K; Bartlett KH; Baer R; Byrnes E; Galanis E; Heitman J; Hoang L; Leslie MJ; MacDougall L; Magill SS; Morshed MG; Marr KA;
    Emerg Infect Dis; 2009 Aug; 15(8):1185-91. PubMed ID: 19757550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA.
    MacDougall L; Kidd SE; Galanis E; Mak S; Leslie MJ; Cieslak PR; Kronstad JW; Morshed MG; Bartlett KH
    Emerg Infect Dis; 2007 Jan; 13(1):42-50. PubMed ID: 17370514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Disease Ecology, Epidemiology, Clinical Manifestations, and Management of Emerging Cryptococcus gattii Complex Infections.
    Diaz JH
    Wilderness Environ Med; 2020 Mar; 31(1):101-109. PubMed ID: 31813737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What makes Cryptococcus gattii a pathogen?
    Bielska E; May RC
    FEMS Yeast Res; 2016 Feb; 16(1):fov106. PubMed ID: 26614308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest.
    Smith RM; Mba-Jonas A; Tourdjman M; Schimek T; DeBess E; Marsden-Haug N; Harris JR
    PLoS One; 2014; 9(2):e88875. PubMed ID: 24586423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decade of experience: Cryptococcus gattii in British Columbia.
    Bartlett KH; Cheng PY; Duncan C; Galanis E; Hoang L; Kidd S; Lee MK; Lester S; MacDougall L; Mak S; Morshed M; Taylor M; Kronstad J
    Mycopathologia; 2012 Jun; 173(5-6):311-9. PubMed ID: 21960040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptococcus gattii infections in multiple states outside the US Pacific Northwest.
    Harris JR; Lockhart SR; Sondermeyer G; Vugia DJ; Crist MB; D'Angelo MT; Sellers B; Franco-Paredes C; Makvandi M; Smelser C; Greene J; Stanek D; Signs K; Nett RJ; Chiller T; Park BJ
    Emerg Infect Dis; 2013 Oct; 19(10):1620-6. PubMed ID: 24050410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen.
    Harris JR; Lockhart SR; Debess E; Marsden-Haug N; Goldoft M; Wohrle R; Lee S; Smelser C; Park B; Chiller T
    Clin Infect Dis; 2011 Dec; 53(12):1188-95. PubMed ID: 22016503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach.
    Hagen F; van Assen S; Luijckx GJ; Boekhout T; Kampinga GA
    Med Mycol; 2010 May; 48(3):528-31. PubMed ID: 19824880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States.
    Iqbal N; DeBess EE; Wohrle R; Sun B; Nett RJ; Ahlquist AM; Chiller T; Lockhart SR;
    J Clin Microbiol; 2010 Feb; 48(2):539-44. PubMed ID: 20007380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates.
    Lockhart SR; Iqbal N; Harris JR; Grossman NT; DeBess E; Wohrle R; Marsden-Haug N; Vugia DJ
    PLoS One; 2013; 8(9):e74737. PubMed ID: 24019979
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Applen Clancey S; Ciccone EJ; Coelho MA; Davis J; Ding L; Betancourt R; Glaubiger S; Lee Y; Holland SM; Gilligan P; Sung J; Heitman J
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls in Serological Diagnosis of Cryptococcus gattii Infections.
    Tintelnot K; Hagen F; Han CO; Seibold M; Rickerts V; Boekhout T
    Med Mycol; 2015 Nov; 53(8):874-9. PubMed ID: 26337090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
    Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
    Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11.
    Gast CE; Basso LR; Bruzual I; Wong B
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5478-85. PubMed ID: 23979758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States.
    Byrnes EJ; Li W; Lewit Y; Ma H; Voelz K; Ren P; Carter DA; Chaturvedi V; Bildfell RJ; May RC; Heitman J
    PLoS Pathog; 2010 Apr; 6(4):e1000850. PubMed ID: 20421942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of Cryptococcus gattii--Pacific Northwest, 2004-2010.
    Center of Disease Control and Prevention
    Am J Transplant; 2011 Sep; 11(9):1989-92. PubMed ID: 21884409
    [No Abstract]   [Full Text] [Related]  

  • 20. Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest.
    Hagen F; Ceresini PC; Polacheck I; Ma H; van Nieuwerburgh F; Gabaldón T; Kagan S; Pursall ER; Hoogveld HL; van Iersel LJ; Klau GW; Kelk SM; Stougie L; Bartlett KH; Voelz K; Pryszcz LP; Castañeda E; Lazera M; Meyer W; Deforce D; Meis JF; May RC; Klaassen CH; Boekhout T
    PLoS One; 2013; 8(8):e71148. PubMed ID: 23940707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.